Guillermo López-Vivanco

4PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPacific Peoples life course
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 28, 2022
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy.

Marta Casarrubios, Mariano Provencio, Ernest Nadal

|Aug 11, 2021
Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy.

Marta Casarrubios, Alberto Cruz-Bermúdez, Ernest Nadal

|Jul 29, 2021
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.

Raquel Laza-Briviesca, Alberto Cruz-Bermúdez, Ernest Nadal

|Jan 16, 2021
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study.

Jaime Feliu, Mónica Jorge Fernández, Teresa Macarulla

Pageof 1

Frequent Collaborators

3 joint publications

Edel Del Barco

3 joint publications

Alberto Cruz-Bermúdez

3 joint publications

Ernest Nadal

3 joint publications

Amelia Insa